SLC5A2 and type 2 diabetes mellitus: In summary, as a new blood sugar lowering drug, SGLT2 inhibitors can effectively and safely lower blood sugar levels, redress the deficiencies of other blood sugar lowering drugs to a certain extent, and meet the needs of more T2DM patients.